Differential expression of lumican and fatty acid binding protein-1: New insights into the histologic spectrum of nonalcoholic fatty liver disease #
Michael Charlton(Madrigal Pharmaceuticals (United States)), Michael G. Sarr(Mayo Clinic in Arizona)
Cited by 149
Related Papers
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
Investigation of PNPLA3 and IL28B Genotypes on Diabetes and Obesity After Liver Transplantation: Insight Into Mechanisms of Disease
|American Journal of Transplantation|2013|49